Acute skeletal muscle wasting in critical illness.

IMPORTANCE Survivors of critical illness demonstrate skeletal muscle wasting with associated functional impairment. OBJECTIVE To perform a comprehensive prospective characterization of skeletal muscle wasting, defining the pathogenic roles of altered protein synthesis and breakdown. DESIGN, SETTING, AND PARTICIPANTS Sixty-three critically ill patients (59% male; mean age: 54.7 years [95% CI, 50.0-59.6 years]) with an Acute Physiology and Chronic Health Evaluation II score of 23.5 (95% CI, 21.9-25.2) were prospectively recruited within 24 hours following intensive care unit (ICU) admission from August 2009 to April 2011 at a university teaching and a community hospital in England. Patients were recruited if older than 18 years and were anticipated to be intubated for longer than 48 hours, to spend more than 7 days in critical care, and to survive ICU stay. MAIN OUTCOMES AND MEASURES Muscle loss was determined through serial ultrasound measurement of the rectus femoris cross-sectional area (CSA) on days 1, 3, 7, and 10. In a subset of patients, the fiber CSA area was quantified along with the ratio of protein to DNA on days 1 and 7. Histopathological analysis was performed. In addition, muscle protein synthesis, breakdown rates, and respective signaling pathways were characterized. RESULTS There were significant reductions in the rectus femoris CSA observed at day 10 (−17.7% [95% CI, −25.9% to 8.1%]; P < .001). In the 28 patients assessed by all 3 measurement methods on days 1 and 7, the rectus femoris CSA decreased by 10.3% (95% CI, 6.1% to 14.5%), the fiber CSA by 17.5% (95% CI, 5.8% to 29.3%), and the ratio of protein to DNA by 29.5% (95% CI, 13.4% to 45.6%). Decrease in the rectus femoris CSA was greater in patients who experienced multiorgan failure by day 7 (−15.7%; 95% CI, −27.7% to 11.4%) compared with single organ failure (−3.0%; 95% CI, −5.3% to 2.1%) (P < .001), even by day 3 (−8.7% [95% CI, −59.3% to 50.6%] vs −1.8% [95% CI, −12.3% to 10.5%], respectively; P = .03). Myofiber necrosis occurred in 20 of 37 patients (54.1%). Protein synthesis measured by the muscle protein fractional synthetic rate was depressed in patients on day 1 (0.035%/hour; 95% CI, 0.023% to 0.047%/hour) compared with rates observed in fasted healthy controls (0.039%/hour; 95% CI, 0.029% to 0.048%/hour) (P = .57) and increased by day 7 (0.076% [95% CI, 0.032%-0.120%/hour]; P = .03) to rates associated with fed controls (0.065%/hour [95% CI, 0.049% to 0.080%/hour]; P = .30), independent of nutritional load. Leg protein breakdown remained elevated throughout the study (8.5 [95% CI, 4.7 to 12.3] to 10.6 [95% CI, 6.8 to 14.4] μmol of phenylalanine/min/ideal body weight × 100; P = .40). The pattern of intracellular signaling supported increased breakdown (n = 9, r = −0.83, P = .005) and decreased synthesis (n = 9, r = −0.69, P = .04). CONCLUSIONS AND RELEVANCE Among these critically ill patients, muscle wasting occurred early and rapidly during the first week of critical illness and was more severe among those with multiorgan failure compared with single organ failure. These findings may provide insights into skeletal muscle wasting in critical illness.

[1]  E. Barreiro,et al.  Feast or famine in the intensive care unit: does it really matter? , 2013, American journal of respiratory and critical care medicine.

[2]  D. Needham,et al.  Physical and cognitive performance of patients with acute lung injury 1 year after initial trophic versus full enteral feeding. EDEN trial follow-up. , 2013, American journal of respiratory and critical care medicine.

[3]  D. Needham,et al.  One year outcomes in patients with acute lung injury randomised to initial trophic or full enteral feeding: prospective follow-up of EDEN randomised trial , 2013, BMJ.

[4]  C. Pichard,et al.  Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomised controlled clinical trial , 2013, The Lancet.

[5]  T. Walsh,et al.  Impact of intensive care unit organ failures on mortality during the five years after a critical illness. , 2012, American journal of respiratory and critical care medicine.

[6]  Z. Puthucheary,et al.  Neuromuscular blockade and skeletal muscle weakness in critically ill patients: time to rethink the evidence? , 2012, American journal of respiratory and critical care medicine.

[7]  M. Rennie,et al.  Effect of tumor burden and subsequent surgical resection on skeletal muscle mass and protein turnover in colorectal cancer patients. , 2012, The American journal of clinical nutrition.

[8]  T. Rice,et al.  Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. , 2012, JAMA.

[9]  J. Wernerman,et al.  Protein metabolism and gene expression in skeletal muscle of critically ill patients with sepsis. , 2012, Clinical science.

[10]  G. Van den Berghe,et al.  Early versus Late Parenteral Nutrition in Critically Ill Adults , 2011, The New England journal of medicine.

[11]  P. Greenhaff,et al.  Novel events in the molecular regulation of muscle mass in critically ill patients , 2011, The Journal of physiology.

[12]  J. Kirk-Bayley,et al.  Functional Disability 5 Years after Acute Respiratory Distress Syndrome , 2011 .

[13]  Arthur S Slutsky,et al.  Functional disability 5 years after acute respiratory distress syndrome. , 2011, The New England journal of medicine.

[14]  K. Nair,et al.  Preferential skeletal muscle myosin loss in response to mechanical silencing in a novel rat intensive care unit model: underlying mechanisms , 2011, The Journal of physiology.

[15]  K. Langa,et al.  Long-term cognitive impairment and functional disability among survivors of severe sepsis. , 2010, JAMA.

[16]  J. Wernerman,et al.  Protein metabolism in leg muscle following an endotoxin injection in healthy volunteers. , 2009, Clinical science.

[17]  M. Rennie,et al.  Blunting of insulin inhibition of proteolysis in legs of older subjects may contribute to age-related sarcopenia. , 2009, The American journal of clinical nutrition.

[18]  M. Polkey,et al.  The prevalence of quadriceps weakness in COPD and the relationship with disease severity , 2009, European Respiratory Journal.

[19]  J Moxham,et al.  Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD , 2009, Thorax.

[20]  Marco Sandri,et al.  Signaling in muscle atrophy and hypertrophy. , 2008, Physiology.

[21]  R. Wolfe,et al.  Atrophy and impaired muscle protein synthesis during prolonged inactivity and stress. , 2006, The Journal of clinical endocrinology and metabolism.

[22]  E. Wouters,et al.  Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[23]  G. Biolo,et al.  Inverse regulation of protein turnover and amino acid transport in skeletal muscle of hypercatabolic patients. , 2002, The Journal of clinical endocrinology and metabolism.

[24]  T. J. Peters,et al.  Alcoholic skeletal muscle myopathy: definitions, features, contribution of neuropathy, impact and diagnosis , 2001, European journal of neurology.

[25]  R. Wolfe,et al.  Rapid Report , 2001 .

[26]  J. Walls,et al.  Role of an improvement in acid-base status and nutrition in CAPD patients. , 1997, Kidney international.

[27]  C. Catani,et al.  Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis. , 1996, Heart.

[28]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[29]  D. Recupero,et al.  Critical illness myopathy and neuropathy , 1996, The Lancet.

[30]  R. Rogers,et al.  Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. , 1996, American journal of respiratory and critical care medicine.

[31]  S. Hauptmann,et al.  Skeletal muscle oedema and muscle fibre necrosis during septic shock. Observations with a porcine septic shock model , 1994, Virchows Archiv.

[32]  R. Griffiths,et al.  Necrotizing myopathy in critically‐ill patients , 1991, The Journal of pathology.

[33]  R. Griffiths,et al.  Conchotome and needle percutaneous biopsy of skeletal muscle. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[34]  T. Rice,et al.  Initial Trophic vs Full Enteral Feeding in Patients With Acute Lung Injury: The EDEN Randomized Trial , 2012 .

[35]  P. Essén,et al.  Tissue protein synthesis rates in critically ill patients. , 1998, Critical care medicine.

[36]  M. Rennie,et al.  Muscle protein turnover and the wasting due to injury and disease. , 1985, British medical bulletin.